Exxonmobil Investment Management Inc. TX Sells 6,775 Shares of CIGNA Co. (CI)

Exxonmobil Investment Management Inc. TX lessened its stake in shares of CIGNA Co. (NYSE:CI) by 14.7% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 39,203 shares of the health services provider’s stock after selling 6,775 shares during the period. Exxonmobil Investment Management Inc. TX’s holdings in CIGNA were worth $7,962,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in the business. Northwestern Mutual Wealth Management Co. boosted its stake in shares of CIGNA by 2.3% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,760 shares of the health services provider’s stock worth $295,000 after acquiring an additional 40 shares during the period. Veritable L.P. boosted its stake in shares of CIGNA by 0.5% in the second quarter. Veritable L.P. now owns 8,220 shares of the health services provider’s stock worth $1,376,000 after acquiring an additional 41 shares during the period. MML Investors Services LLC boosted its stake in shares of CIGNA by 0.8% in the second quarter. MML Investors Services LLC now owns 5,774 shares of the health services provider’s stock worth $967,000 after acquiring an additional 43 shares during the period. Argent Capital Management LLC boosted its stake in shares of CIGNA by 2.0% in the second quarter. Argent Capital Management LLC now owns 2,613 shares of the health services provider’s stock worth $437,000 after acquiring an additional 50 shares during the period. Finally, Eqis Capital Management Inc. boosted its stake in shares of CIGNA by 3.1% in the third quarter. Eqis Capital Management Inc. now owns 8,949 shares of the health services provider’s stock worth $1,673,000 after acquiring an additional 267 shares during the period. 87.74% of the stock is owned by institutional investors and hedge funds.

In other CIGNA news, insider Christopher J. Hocevar sold 8,387 shares of the company’s stock in a transaction that occurred on Monday, November 27th. The stock was sold at an average price of $200.32, for a total transaction of $1,680,083.84. Following the sale, the insider now directly owns 12,363 shares in the company, valued at $2,476,556.16. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Chairman Isaiah Harris, Jr. sold 212 shares of the company’s stock in a transaction that occurred on Monday, December 11th. The shares were sold at an average price of $209.35, for a total value of $44,382.20. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 34,936 shares of company stock worth $6,979,204. Company insiders own 1.30% of the company’s stock.

Shares of CIGNA Co. (CI) opened at $207.87 on Wednesday. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.39 and a quick ratio of 0.39. The company has a market capitalization of $51,250.00, a PE ratio of 22.77, a P/E/G ratio of 1.44 and a beta of 0.51. CIGNA Co. has a 52-week low of $133.52 and a 52-week high of $212.46.

CIGNA (NYSE:CI) last posted its earnings results on Thursday, November 2nd. The health services provider reported $2.83 EPS for the quarter, topping analysts’ consensus estimates of $2.36 by $0.47. The company had revenue of $10.38 billion for the quarter, compared to the consensus estimate of $10.17 billion. CIGNA had a return on equity of 18.85% and a net margin of 5.74%. The firm’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same period in the previous year, the business earned $1.94 earnings per share. analysts anticipate that CIGNA Co. will post 10.34 EPS for the current fiscal year.

A number of equities analysts have recently weighed in on CI shares. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $191.00 price objective on shares of CIGNA in a research note on Sunday, September 17th. Zacks Investment Research raised CIGNA from a “hold” rating to a “buy” rating and set a $214.00 price objective for the company in a research note on Monday, October 9th. Jefferies Group upped their price objective on CIGNA from $201.00 to $221.00 and gave the stock a “buy” rating in a research note on Friday, October 13th. BMO Capital Markets began coverage on CIGNA in a research report on Monday, October 16th. They issued a “market perform” rating and a $210.00 target price on the stock. Finally, Credit Suisse Group began coverage on CIGNA in a research report on Thursday, November 2nd. They issued an “outperform” rating and a $219.00 target price on the stock. Three equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the stock. CIGNA has a consensus rating of “Buy” and an average price target of $205.18.

COPYRIGHT VIOLATION WARNING: This piece of content was published by Markets Daily and is owned by of Markets Daily. If you are viewing this piece of content on another domain, it was stolen and republished in violation of U.S. & international trademark and copyright legislation. The original version of this piece of content can be accessed at https://www.themarketsdaily.com/2018/01/10/exxonmobil-investment-management-inc-tx-sells-6775-shares-of-cigna-co-ci.html.

CIGNA Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CIGNA Co. (NYSE:CI).

Institutional Ownership by Quarter for CIGNA (NYSE:CI)

Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply